Gulf International Bank UK Ltd Increases Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Gulf International Bank UK Ltd grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 5.8% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 30,488 shares of the medical equipment provider’s stock after purchasing an additional 1,671 shares during the quarter. Gulf International Bank UK Ltd’s holdings in Intuitive Surgical were worth $12,167,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Provence Wealth Management Group acquired a new position in Intuitive Surgical in the 4th quarter valued at about $276,000. Portside Wealth Group LLC raised its stake in shares of Intuitive Surgical by 8.2% during the fourth quarter. Portside Wealth Group LLC now owns 816 shares of the medical equipment provider’s stock worth $275,000 after purchasing an additional 62 shares during the last quarter. Sequoia Financial Advisors LLC lifted its holdings in shares of Intuitive Surgical by 58.0% during the fourth quarter. Sequoia Financial Advisors LLC now owns 8,315 shares of the medical equipment provider’s stock worth $2,805,000 after purchasing an additional 3,054 shares during the period. Public Employees Retirement System of Ohio grew its position in Intuitive Surgical by 5.4% in the 4th quarter. Public Employees Retirement System of Ohio now owns 191,283 shares of the medical equipment provider’s stock valued at $64,531,000 after buying an additional 9,869 shares during the last quarter. Finally, HCR Wealth Advisors increased its stake in Intuitive Surgical by 26.3% in the 4th quarter. HCR Wealth Advisors now owns 1,042 shares of the medical equipment provider’s stock valued at $352,000 after buying an additional 217 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Intuitive Surgical

In other news, Director Alan J. Levy sold 2,000 shares of the firm’s stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total value of $741,400.00. Following the sale, the director now directly owns 25,319 shares of the company’s stock, valued at $9,385,753.30. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other news, Director Alan J. Levy sold 2,000 shares of the business’s stock in a transaction that occurred on Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total transaction of $741,400.00. Following the sale, the director now directly owns 25,319 shares in the company, valued at $9,385,753.30. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Mark J. Rubash sold 1,709 shares of the firm’s stock in a transaction on Friday, May 3rd. The stock was sold at an average price of $380.00, for a total value of $649,420.00. Following the completion of the transaction, the director now directly owns 16,051 shares of the company’s stock, valued at $6,099,380. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 17,956 shares of company stock valued at $6,927,011. 0.90% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of research analysts recently weighed in on ISRG shares. Jefferies Financial Group upped their price objective on Intuitive Surgical from $365.00 to $375.00 and gave the stock a “hold” rating in a report on Friday, April 19th. Stifel Nicolaus upped their target price on shares of Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, April 8th. StockNews.com cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Thursday, February 29th. Piper Sandler boosted their price target on Intuitive Surgical from $425.00 to $435.00 and gave the stock an “overweight” rating in a research note on Friday, April 19th. Finally, BTIG Research raised their price objective on Intuitive Surgical from $412.00 to $421.00 and gave the company a “buy” rating in a research note on Friday, April 19th. Five equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $403.67.

Get Our Latest Research Report on Intuitive Surgical

Intuitive Surgical Trading Up 0.0 %

Intuitive Surgical stock traded up $0.01 during midday trading on Friday, reaching $432.56. 2,769,405 shares of the stock traded hands, compared to its average volume of 1,125,404. The firm has a fifty day moving average price of $397.13 and a two-hundred day moving average price of $378.19. The firm has a market cap of $153.43 billion, a price-to-earnings ratio of 78.08, a PEG ratio of 5.59 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $254.85 and a fifty-two week high of $437.20.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last issued its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.40 by $0.10. The firm had revenue of $1.89 billion during the quarter, compared to analyst estimates of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The firm’s quarterly revenue was up 11.5% on a year-over-year basis. During the same period last year, the company posted $1.00 EPS. Analysts anticipate that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Articles

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.